Metabolic effects of alternate-day fasting in males with obesity with or without type 2 diabetes

被引:5
|
作者
Ingersen, Arthur [1 ,2 ]
Helset, Hildegunn Romma [1 ]
Calov, Monika [1 ]
Chabanova, Elizaveta [3 ]
Harreskov, Eva Gjerlevsen [1 ]
Jensen, Christina [1 ]
Hansen, Christina Neigaard [1 ]
Prats, Clara [1 ]
Helge, Jorn Wulff [1 ]
Larsen, Steen [1 ,4 ]
Dela, Flemming [1 ,2 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Dept Biomed Sci,Xlab, Copenhagen, Denmark
[2] Bispebjerg Frederiksberg Univ Hosp, Dept Geriatr, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Dept Diagnost Radiol, Copenhagen, Denmark
[4] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland
关键词
fasting; glucose homeostasis; insulin sensitivity; visceral fat; weight loss; beta-cell; BETA-CELL FUNCTION; INDUCED WEIGHT-LOSS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; LIVER; SECRETION; DIET;
D O I
10.3389/fphys.2022.1061063
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Alternate-day fasting induces oscillations in energy stores. We hypothesized that repeated oscillations increases insulin secretion and sensitivity, and improve metabolic health in patients with obesity with or without type 2 diabetes (T2DM). Twenty-three male patients fasted every other day for 30 h for 6 weeks. Experiments included resting energy expenditure, continuous glucose monitoring, intravenous glucose tolerance test, euglycemic hyperinsulinemic clamp, body composition, hepatic triglyceride content, muscle biopsies which were performed at baseline, during 3 weeks without allowed weight loss, and after additional 3 weeks with weight loss. Bodyweight decreased & SIM;1% and further & SIM;3% during weeks one to three and four to six, respectively (p < 0.05). Only minor changes in fat mass occurred in weeks 1-3. With weight loss, visceral fat content decreased by 13 +/- 3% and 12 +/- 2% from baseline in patients with and without T2DM, respectively (p < 0.05). Hepatic triglyceride content decreased by 17 +/- 9% and 36 +/- 9% (with diabetes) and 27 +/- 8% and 40 +/- 8% (without diabetes) from baseline to week 3 and week 6, respectively (all p < 0.05). Muscle lipid and glycogen content oscillated with the intervention. Glucose homeostasis, insulin secretion and sensitivity was impaired in patients with T2DM and did not change without weight loss, but improved (p < 0.05) when alternate day fasting was combined with weight loss. In conclusion, alternate-day fasting is feasible in patients with obesity and T2DM, and decreases visceral fat and liver fat deposits. Energy store oscillations by alternate-day fasting do not improve insulin secretion or sensitivity per se.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Alternate-day fasting and chronic disease prevention: a review of human and animal trials
    Varady, Krista A.
    Hellerstein, Marc K.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (01): : 7 - 13
  • [22] Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns
    Singh, Harmanjit
    Joshi, Dinesh
    Narula, Seerat
    Singla, Mandeep
    Rohilla, Ravi
    Singh, Jagjit
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (02) : 197 - 203
  • [23] The effects of alternate-day fasting on sleep and physical activity in poor sleeping adults: A randomized control trial
    Deru, Landon S.
    Jacobsen, Cameron G.
    Gipson, Elizabeth Z.
    Graves, Parker G.
    Stevens, Andrew J.
    Duncan, Garrett B.
    Christensen, William F.
    Bailey, Bruce W.
    JOURNAL OF SLEEP RESEARCH, 2025, 34 (02)
  • [24] PULMONARY AND ADRENAL EFFECTS OF ALTERNATE-DAY CORTICOSTEROID THERAPY
    FALLIERS, CJ
    MOLK, L
    CARDOSO, RRD
    CHAI, H
    BANE, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1972, 49 (03) : 156 - +
  • [25] A Randomized Pilot Study Comparing Zero-Calorie Alternate-Day Fasting to Daily Caloric Restriction in Adults with Obesity
    Catenacci, Victoria A.
    Pan, Zhaoxing
    Ostendorf, Danielle
    Brannon, Sarah
    Gozansky, Wendolyn S.
    Mattson, Mark P.
    Martin, Bronwen
    MacLean, Paul S.
    Melanson, Edward L.
    Donahoo, William Troy
    OBESITY, 2016, 24 (09) : 1874 - 1883
  • [26] Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without type 2 diabetes - Intracellular insulin in obesity and Type 2 diabetes
    Benzi, L
    Ciccarone, AM
    Cecchetti, P
    DiCianni, G
    Caricato, F
    Trincavelli, L
    Volpe, L
    Navalesi, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 46 (03) : 231 - 237
  • [27] Comparative Impact of Alternate-Day Fasting and Time-Restricted Feeding on Placental Function and Fetal Development in Maternal Obesity
    Liu, Siyuan
    Hua, Lun
    Mo, Xi
    Lei, Bing
    Zhang, Ruihao
    Zhou, Shihao
    Jiang, Xuemei
    Fang, Zhengfeng
    Feng, Bin
    Che, Lianqiang
    Xu, Shengyu
    Lin, Yan
    Wu, De
    Zhuo, Yong
    Jin, Chao
    NUTRIENTS, 2025, 17 (01)
  • [28] PULMONARY AND ADRENAL EFFECTS OF ALTERNATE-DAY CORTICOSTEROID THERAPY
    FALLIERS, CJ
    CHAI, H
    MOLK, L
    CARDOSO, RDA
    ANNALS OF ALLERGY, 1971, 29 (04): : 224 - &
  • [29] The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients
    Chaia-Semerena, Genny Margarita
    Vargas-Camano, Maria Eugenia
    Alonso-Bello, Cesar Daniel
    Guillen-Toledo, Jorge Javier
    Guido-Bayardo, Ricardo Leopoldo
    Lozano-Patino, Fernando
    Temix-Delfin, Mariano Daniel
    Castrejon-Vazquez, Maria Isabel
    AUTOIMMUNE DISEASES, 2020, 2020
  • [30] EFFECTS OF ALTERNATE-DAY STEROID THERAPY IN ASTHMATIC CHILDREN
    SIEGEL, SC
    HEIMLICH, EM
    RICHARDS, W
    TAYLOR, WF
    KELLEY, VC
    JOURNAL OF ALLERGY, 1965, 36 (02): : 209 - &